VRS
ICPT

Virginia Retirement Systems’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Virginia Retirement Systems’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-56,000
Closed -$619K – 1068
2023
Q2 		$619K Buy
56,000
+1,200
+2% +$16.7K 0.01% 671
2023
Q1 		$736K Sell
54,800
-10,400
-16% -$180K 0.01% 627
2022
Q4 		$807K Buy
65,200
+8,700
+15% +$123K 0.01% 670
2022
Q3 		$788K Buy
+56,500
New +$910K 0.01% 654
2022
Q1 		$617K Buy
37,900
+1,800
+5% +$28.2K 0.01% 794
2021
Q4 		$588 Hold
36,100
– – ﹤0.01% 803
2021
Q3 		$536K Buy
36,100
+6,000
+20% +$96K 0.01% 780
2021
Q2 		$601K Buy
30,100
+12,200
+68% +$242K 0.01% 787
2021
Q1 		$413K Buy
17,900
+5,300
+42% +$148K ﹤0.01% 926
2020
Q4 		$311K Buy
+12,600
New +$418K ﹤0.01% 971
2020
Q3 		– Sell
-4,500
Closed -$216K – 1196
2020
Q2 		$216K Sell
4,500
-600
-12% -$46.4K ﹤0.01% 1022
2020
Q1 		$321K Buy
+5,100
New +$458K ﹤0.01% 919

Other funds holding ICPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Virginia Retirement Systems's ICPT Position: Q3 2023 in Review

Virginia Retirement Systems sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 56,000 shares — an estimated $619K sold.

Virginia Retirement Systems first reported a position in ICPT in Q1 2020 and held it in 12 quarters. The position peaked at $807K in Q4 2022. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

  • Virginia Retirement Systems reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
  • Virginia Retirement Systems sold 56,000 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $619K.
  • Virginia Retirement Systems first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2020 and held it in 12 quarters.
  • Virginia Retirement Systems's Intercept Pharmaceuticals, Inc. position peaked at $807K in Q4 2022.
  • 146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Virginia Retirement Systems's 13F filing for Q3 2023, filed 2 Jan 2024.